SpeculatingStocks   UserStream  Reactions  Data  Stock Buzz  Market  Pre  AH  Technicals  ETFs  Articles  Picks  Compare Stocks  Portal  Buckets  Post  Join  ☰
Remember
Forgot Pass?
 
+
 
+
→  Do You Know the Most Important and Timely Stock Plays During the Trading Week? View Our Power Rankings.
 
hatwahes Followed headlines. 6 days ago
hatwahes Followed above-average-volume. 6 days ago
hatwahes Followed current-movers-gainers. 6 days ago
anonusers Placed a 'Buy' Sentiment on VSTR. More than a week ago
anonusers Placed a 'Buy' Sentiment on VSTR. More than a week ago
anonusers Placed a 'Buy' Sentiment on UNVC. More than a week ago
Yankeez_2 Followed stockpicks. More than a week ago
Yankeez_2 Followed current-movers-gainers. More than a week ago
Yankeez_2 Followed tpc. More than a week ago
 
Most Discussed Stocks through Posts and Reactions on SpeculatingStocks  UNVC  •  ACB  •  BBGP  •  UGAZ  •  CNCG  •  RAD  •  LULU  •  SNAP  •  IRBT  •  TRK  Performance based equity crowdfunding for hyper growth companies including public companies.
ABBV Stream, Posts, Sentiment, Activity ↘
'BUYS'  VSTR  VSTR  UNVC  'SELLS'  SFOR  FBER  ACB

  AXGC  AKVA  NLTX  VLRDF  PTXKY  LEAF
 

ABBV
 
 

ABBV (AbbVie Inc.) · Research · Financials · News · Reactions · React Anonymously to $ABBV

 
  $96.13   -0.86   -0.89% 🕐  

 

 
  Follow Important Email Alerts on Stocks like ABBV from SpeculatingStocks.com.

Sign up for our Email Newsletter.






  
 

ABBV 'Buy' / 'Sell' Stats
 
Sentiment Over the Last:  
  10-Mins: B:0 S:0  
  1-Hour: B:0 S:0  
6-Hours: B:0 S:0
1-Day: B:0 S:0
3-Days: B:0 S:0
1-Week: B:0 S:0
and more... sign up.
More ABBV Social Data
 

ABBV in Data Terminal

  
Research ABBV /w Social & Financial Data on ABBV
 

Top Stories Today 2m

  
 

ABBV Stats
 

Followers: 1

 		 
 

'Buys': 1

  
 

'Sells': 0

  
  'Buys' 7 AM:  0  
  'Sells' 7 AM:  0  
 

Go to a Symbol Page
 
  Go to a User Profile
 
 

Follow ABBV on Pulse
 
Sign Up for SpeculatingStocks Pulse: A Social Network for Investors
 

Global Streams
 
PulseStream
SpecStream
UserStream
Reactions
EchoStream
 

Stock Data Terminal

  
Stock Market Data
  SpecStream Components
 
SpecStream Trending Stock Exchanges S&P Premarket Gainers & Losers Morning Earning Releases Futures After the Bell Earning Releases Technical Indicators ETF Movers Market Cap Milestones Current Movers - Gainers Current Movers - Decliners Headlines Media Buzz Economic News Top Stories Pulse User Buys Pulse User Sells B/S Today Pos. Sent. Milestones B/S Today Neg. Sent. Milestones Stock Follower Milestones Corporate Alerts Short Squeeze Alerts Price to Earnings PE Alerts Price to Sales PS Alerts Price to Book PB Alerts Insider Holding Alerts Institutional Holding Alerts Low Float Stocks Profitable or Not Cash Flow Positive High Beta Volatile Stocks Stocks Followed by Users
 
 

$ABBV Stream · Posts

$ABBV Reactions		    

AbbVie Inc. ($ABBV)


AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of phar... More · Chart
Corporate Alerts
$ABBV AbbVie unit Allergen received Complete Response Letter from FDA on Biologics License Application for Abicipar pegol.
More than a wk ago | 0 buys, 0 sells
+3
React Anonymously
specstocks
Moments ago | 0 buys, 0 sells
+6
React Anonymously
Corporate Alerts
$ABBV AbbVie: FDA will review a sNDA for IMBRUVICA in combination with rituximab for the treatment of Waldenstrm's macroglobulinemia.
More than a wk ago | 0 buys, 0 sells
+3
React Anonymously
Corporate Alerts
$ABBV AbbVie: FDA has accepted the company's sBLA to expand the BOTOX prescribing information for the treatment of signed and symptoms of detrusor (bladder muscle) overactivity associated with an underlying neurologic condition.
More than a wk ago | 0 buys, 0 sells
+3
React Anonymously
specstocks
Moments ago | 0 buys, 0 sells
+6
React Anonymously
Price to Earnings PE Alerts
$ABBV (AbbVie Inc.) is trading at a trailing PE of less than 25 with a Price to Earnings ratio of only 17.12.
More than a wk ago | 0 buys, 0 sells
+4
React Anonymously
Headlines
$ABBV (AbbVie Inc.) Headline: A Yes Vote for AMD Stock
More than 2 wks ago | 0 buys, 0 sells
+10
React Anonymously
Corporate Alerts
$ABBV AbbVie announced upadacitinib met co-primary endpoints in Phase 3 study for Atopic Dermatitis.
More than 2 wks ago | 0 buys, 0 sells
+3
React Anonymously
Headlines
$ABBV (AbbVie Inc.) Headline: AbbVie Declares Quarterly Dividend
More than 2 wks ago | 0 buys, 0 sells
+10
React Anonymously
specstocks
Moments ago | 0 buys, 0 sells
+6
React Anonymously
Institutional Holding Alerts
$ABBV (AbbVie Inc.) has significant institutional ownership of at least 20% with institutional ownership of 50.74%.
More than 2 wks ago | 0 buys, 0 sells
+1
React Anonymously
Price to Earnings PE Alerts
$ABBV (AbbVie Inc.) is trading at a trailing PE of less than 25 with a Price to Earnings ratio of only 16.47.
More than 2 wks ago | 0 buys, 0 sells
+4
React Anonymously
Corporate Alerts
$ABBV AbbVie announced FDA approval of JUVDERM VOLUMA XC for the augmentation of the chin region to improve the chin profile in adults over the age of 21.
More than 2 wks ago | 0 buys, 0 sells
+3
React Anonymously
Corporate Alerts
$ABBV AbbVie reported VENCLEXTA/VENCLYXTO plus Azacitidine demonstrated statistically significant overall survival benefit and improved remission rates.
More than 2 wks ago | 0 buys, 0 sells
+3
React Anonymously
specstocks
Moments ago | 0 buys, 0 sells
+6
React Anonymously
+10
React Anonymously
Corporate Alerts
$ABBV AbbVie announced Phase 3b head-to-head data showing superior rates of skin clearance for SKYRIZI to COSENTYX.
More than 3 wks ago | 0 buys, 0 sells
+3
React Anonymously
Corporate Alerts
$ABBV AbbVie announced new data from a Phase 2a study of ABBV-3373 in adult patients with moderate to severe rheumatoid arthritis.
More than 3 wks ago | 0 buys, 0 sells
+3
React Anonymously
Corporate Alerts
$ABBV AbbVie reported data showing RINVOQ (upadacitinib) met primary and key secondary endpoints in Phase 3 head-to-head study versus ORENCIA.
More than 3 wks ago | 0 buys, 0 sells
+3
React Anonymously
specstocks
Moments ago | 0 buys, 0 sells
+6
React Anonymously
Corporate Alerts
$ABBV AbbVie announced results showing that once daily upadacitinib continued to improve signed and symptoms in patients with rheumatoid arthritis at 72 and 84 weeks in the SELECT-COMPARE and SELECT-MONOTHERAPY Phase 3 clinical trials.
More than 1 mo ago | 0 buys, 0 sells
+3
React Anonymously
+10
React Anonymously
Corporate Alerts
$ABBV AbbVie confirmed FDA approval of ORIAHNN capsules for the management of heavy menstrual bleeding due to uterine fibroids in pre-menopausal women.
More than 1 mo ago | 0 buys, 0 sells
+3
React Anonymously
Corporate Alerts
$ABBV AbbVie submitted regulatory applications for RINVOQ for the treatment of adults with active psoriatic arthritis to the FDA and EMA.
More than 1 mo ago | 0 buys, 0 sells
+3
React Anonymously
specstocks
Moments ago | 0 buys, 0 sells
+6
React Anonymously
Price to Earnings PE Alerts
$ABBV (AbbVie Inc.) is trading at a trailing PE of less than 25 with a Price to Earnings ratio of only 16.40.
More than 1 mo ago | 0 buys, 0 sells
+4
React Anonymously

 



Go to Reactions Related to ABBV!

 

Reactions Related to $ABBV · All Reactions Stream Live

  



Your reaction and other reactions to $ABBV pulses will show here!

Post a reaction by clicking the "React Anonymously" link in any of the pulse posts in the stream above. No account required.

Want to react with an account? Get a Free Account.
 
 

ABBV Sentiment Today (Since 7 AM ET)

 
 

0

 
 

Live ABBV Activity

 
OptionStrategy Placed a 'Buy' Sentiment on ABBV.
More than a week ago
More than a week ago
Be the Next Pulse User to Follow, 'Buy', or 'Sell' ABBV.


  The Revolution in Speculation Continues... 23,491 symbol pages... 1068 users... 2,493,128 pulses... not one unhappy user. Sign up now, free!

Newest SpeculatingStocks Pulse User 

hatwahes
  1248 Crowdsourced Stock Ratings Inside...
 

ABBV Snapshot · Research ABBV

 
 

ABBV

  (More Inside)      
  Volume: 14,568,404  
  Market Cap: $169.41B  
  Exchange: NYSE  
  Website: http://www.abbvie.com  
  More ABBV Metrics  
 
 
  
   
   
  Industry: Health Care/Life Sciences  
  AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology; oncology, including...  
 
More ABBV Corporate Data 		 
 

ABBV Buzz

 
 

Headlines for AbbVie Inc. (ABBV)

  
  How gene therapy and CRISPR are helping to cure blindness MarketWatch.com 06/26/20  
  Allergan, an AbbVie Company, and Molecular Partners Receive Complete Response Letter from FDA on Biologics License Application for Abicipar pegol Press Release 06/26/20  
  IMBRUVICA(R) (ibrutinib) Seeks to Expand U.S. Label with Long-Term Data in Waldenström's Macroglobulinemia (WM) Press Release 06/23/20  
  FDA Accepts Supplemental Biologics License Application (sBLA) for BOTOX(R) (onabotulinumtoxinA) for the Treatment of Pediatric Patients with Neurogenic Detrusor Overactivity Press Release 06/22/20  
  A Yes Vote for AMD Stock Barron's 06/19/20  
 


News Headlines for AbbVie Inc. (ABBV)